Publications by authors named "Yousuke Aoki"

Claim this Profile
T
Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer.
Yuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, Yousuke Aoki, Yuto Kimura

Strahlenther Onkol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and Clinical Impact of a Cloud-Based PACS System for Specialist Consultations.
Yousuke Aoki, Masaru Sudo, Toshiaki Takeda, Aya Hashimoto, Akira Takamuro

Stud Health Technol Inform· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Inter-rater Reliability and Cost in Pricing for Creating Dataset Focused on Mediolateral Oblique View in Mammography].
Ayako Yagahara, Yousuke Aoki, Mayu Kabeya, Azusa Ogawa, Yuki Tanaka

Nihon Hoshasen Gijutsu Gakkai Zasshi· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Challenge to Standardize the Introduction Process of Medical Equipment and Information Systems in Japan].
Makoto Hayashibara, Masato Horino, Yousuke Aoki, Hiroshi Sakamoto

Nihon Hoshasen Gijutsu Gakkai Zasshi· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy.
Naoto Mikami, Atsuya Takeda, Aya Hashimoto, Toshiaki Takeda, Yuto Kimura, Yousuke Aoki

Clin Lung Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis-4N0M0 Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
Takafumi Nemoto, Atsuya Takeda, Yukinori Matsuo, Noriko Kishi, Takahisa Eriguchi, Yousuke Aoki

JCO Clin Cancer Inform· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated radiotherapy for hepatocellular carcinomas adjacent to the gastrointestinal tract.
Yuichiro Tsurugai, Atsuya Takeda, Takahisa Eriguchi, Naosko Sanuki, Yousuke Aoki

Hepatol Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume.
Yuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Yousuke Aoki

J Radiat Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Participation/Dispatch Reports on International Conferences in 2018].
Yousuke Aoki

Nihon Hoshasen Gijutsu Gakkai Zasshi· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.
Atsuya Takeda, Yuichiro Tsurugai, Naoko Sanuki, Tatsuji Enomoto, Masaharu Shinkai, Yousuke Aoki

J Thorac Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias.
Yuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, Tatsuji Enomoto, Takeshi Kaneko, Yousuke Aoki

Radiother Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
Takahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Yousuke Aoki

Lung Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Yohei Oku, Yousuke Aoki

J Radiat Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Shogo Iwabuchi, Kotaro Matsunaga, Yousuke Aoki

Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.
Takahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, Shuichi Nishimura, Yoshiaki Takagawa, Yousuke Aoki

J Radiat Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy.
Yu Hara, Atsuya Takeda, Takahisa Eriguchi, Naoko Sanuki, Yousuke Aoki

J Radiat Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.
Yohei Oku, Atsuya Takeda, Naoko Sanuki, Yasunobu Sudo, Yoshikazu Oooka, Yousuke Aoki

Pract Radiat Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
Atsuya Takeda, Yohei Oku, Naoko Sanuki, Takahisa Eriguchi, Yousuke Aoki

J Radiat Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
Shuichi Nishimura, Atsuya Takeda, Naoko Sanuki, Satoshi Ishikura, Yohei Oku, Yousuke Aoki

J Thorac Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy.
Atsuya Takeda, Naoko Sanuki, Hirofumi Fujii, Noriko Yokosuka, Shuichi Nishimura, Yousuke Aoki

J Thorac Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.
Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Tatsuji Enomoto, Tetsuya Yokosuka, Yousuke Aoki

Ann Thorac Surg· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.
Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Takeshi Kaneko, Satoshi Morita, Yousuke Aoki

Int J Radiat Oncol Biol Phys· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
Takahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, Yohei Oku, Yousuke Aoki

Int J Radiat Oncol Biol Phys· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
Atsuya Takeda, Etsuo Kunieda, Hirofumi Fujii, Noriko Yokosuka, Yousuke Aoki

Lung Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy.
Atsuya Takeda, Tatsuji Enomoto, Naoko Sanuki, Hiroshi Handa, Yousuke Aoki

Chest· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis